Clinical Trial Update: Adenovirus (RGDCRAdCOX2F) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating an adenovirus therapy, RGDCRAdCOX2F, for pancreatic adenocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• RGDCRAdCOX2F (RGD-CRAd COX2F)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Adenocarcinoma of Pancreas | Phase 1 | Status: RECRUITING